HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
How clinicians are viewing Veptigastrant vs SERDs
Survey impressions show investigators see similar profiles; Hamilton notes subtle tolerability advantages for PROTACs.
Play episode from 20:35
Transcript
